The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Stéphane Clemenceau sits on this spectrum.
This scientist: 108 publications — 21st percentile
21% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Stéphane Clemenceau sits on this spectrum.
This scientist: 41 D-Index — 19th percentile
19% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Stéphane Clemenceau is affiliated with Université Paris Cité in France. Their research primarily spans the fields of Medicine and Neuroscience, focusing notably on neurology and cellular and molecular neuroscience. Additional areas of specialization include cognitive neuroscience, psychiatry and mental health, and epidemiology.
The main topics explored in their work cover a wide range of neurological conditions and mechanisms. These include epilepsy research and treatment, vascular malformations diagnosis and treatment, intracranial aneurysms treatment and complications, as well as management of meningioma and schwannoma. Clemenceau's work also addresses EEG and brain-computer interfaces, neuroinflammation and neurodegeneration mechanisms, and adenosine and purinergic signaling.
The scientist has contributed to several peer-reviewed publications in notable journals and books. Among their recent papers are:
Frequently publishing in prestigious venues, Clemenceau's work appears in journals such as:
Collaborative work is a significant part of Clemenceau's research. The scientist's frequent coauthors include:
Stéphane Clemenceau's contributions to epilepsy research, vascular malformations, and intracranial aneurysm treatment align strongly with clinical neurology and neuroscience, reflecting a multidisciplinary approach to neurological disorders.
Ivan Cohen;Vincent Navarro;Stéphane Clemenceau;Michel Baulac
Gilles Huberfeld;Lucia Wittner;Stéphane Clemenceau;Michel Baulac
J. Martinerie;C. Adam;M. Le Van Quyen;M. Baulac
Raphaël Gaillard;Raphaël Gaillard;Stanislas Dehaene;Stanislas Dehaene;Stanislas Dehaene;Claude Adam;Stéphane Clémenceau
Raphaël Gaillard;Lionel Naccache;Lionel Naccache;Philippe Pinel;Stéphane Clémenceau
Stéphane Lehéricy;Hugues Duffau;Philippe Cornu;Laurent Capelle
Benoît Crépon;Vincent Navarro;Dominique Hasboun;Stéphane Clemenceau
Gilles Huberfeld;Liset Menendez de la Prida;Johan Pallud;Ivan Cohen
Jean Isnard;Delphine Taussig;Fabrice Bartolomei;Pierre Bourdillon
Lionel Naccache;Raphaël Gaillard;Claude Adam;Dominique Hasboun
A. Krainik;Stéphane Lehéricy;H. Duffau;M. Vlaicu
Vincent Navarro;Jacques Martinerie;Michel Le Van Quyen;Stéphane Clemenceau
Abderrezak Zouaoui;Mokrane Sahel;Beatrice Marro;Stephane Clemenceau
Sophie Dupont;Marie-Laure Tanguy;Stephane Clemenceau;Claude Adam
M. Le Van Quyen;C. Adam;J. Martinerie;M. Baulac
M Baulac;N De Grissac;D Hasboun;C Oppenheim
Christoph J. Ploner;Bertrand M. Gaymard;Sophie Rivaud-Péchoux;Michel Baulac
Ph. Cornu;G. Chatellier;F. Dagreou;S. Clemenceau
M. Noulhiane;P. Piolino;D. Hasboun;S. Clemenceau
Mélanie Morin-Brureau;Giampaolo Milior;Juliette Royer;Farah Chali
S Lehéricy;D Dormont;F Sémah;S Clémenceau
If you think any of the details on this page are incorrect, let us know.
University of Cyprus
Nutcracker Therapeutics
The University of Texas at Austin
University of Quebec at Montreal
Baylor College of Medicine
Texas A&M University
University of York
University of Southampton
Indian Institute of Technology Madras
The University of Texas at Austin
University of Hong Kong
University of Sydney
University of Maryland, College Park
University of California, San Diego
Polytechnic University of Milan
Osnabrück University
